1. Home
  2. ORA vs RGEN Comparison

ORA vs RGEN Comparison

Compare ORA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ormat Technologies Inc.

ORA

Ormat Technologies Inc.

HOLD

Current Price

$111.75

Market Cap

7.4B

Sector

Utilities

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$141.60

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORA
RGEN
Founded
1965
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.6B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
ORA
RGEN
Price
$111.75
$141.60
Analyst Decision
Buy
Buy
Analyst Count
11
12
Target Price
$127.82
$167.67
AVG Volume (30 Days)
856.3K
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.44%
N/A
EPS Growth
N/A
286.96
EPS
0.71
0.15
Revenue
$719,267,000.00
$141,236,000.00
Revenue This Year
$16.52
$14.30
Revenue Next Year
$3.64
$14.52
P/E Ratio
$158.56
$949.33
Revenue Growth
N/A
35.10
52 Week Low
$84.13
$100.99
52 Week High
$146.39
$175.77

Technical Indicators

Market Signals
Indicator
ORA
RGEN
Relative Strength Index (RSI) 31.50 61.53
Support Level $109.93 $123.05
Resistance Level $114.82 $141.46
Average True Range (ATR) 4.52 6.31
MACD -2.74 0.44
Stochastic Oscillator 16.36 68.45

Price Performance

Historical Comparison
ORA
RGEN

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: